GSK wins FDA approval for hepatitis B drug
GSK won U.S. Food and Drug Administration approval for a hepatitis B drug, according to STAT’s biotech news roundup published October 21, 2026. The roundup says the treatment extends functional cures to far more patients than previous methods. It does not…
